Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Proteostasis Therapeutics, Inc. is not a good value stock. Proteostasis Therapeutics, Inc. is not a good growth stock. Proteostasis Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Proteostasis Therapeutics, Inc..
Log in to see more information.
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the...

News